Courval Valérie, Drolet Sébastien, Bouchard Alexandre, Bouchard Philippe
Department of surgery, Local B1-520, 10 rue de L'Espinay, Pavillon St François d'Assise, CHU de Quebec, Quebec City, G1L 3L5, Quebec, Canada.
Department of surgery, Medical Faculty Pavillon Ferdinand-Vandry, bureau 4873, 1050 avenue de la Medecine, Laval University, Quebec City, G1V 0A6, Quebec, Canada.
BMJ Open Gastroenterol. 2019 Jun 21;6(1):e000305. doi: 10.1136/bmjgast-2019-000305. eCollection 2019.
The objective of this study was to review the postoperative and short-term oncological outcomes of our first cohort of patients having had a transanal (Ta) approach for primary or recurrent rectal cancer.
A retrospective chart review was performed on all cases of Ta dissection occurring between 2013 and 2016. We reviewed data concerning case selection, tumour characteristics, perioperative and postoperative data and final pathology.
A total of 24 males were operated for primary (92% (22/24)) or recurrent rectal cancer (8.3% (2/24)). Four patients (16.7% (4/24)) had a history of previous rectal surgery and two had a history of previous Ta total mesorectal excision (TME). A majority of patients were obese, with 58.3% (14/24) having a body mass index >30. The laparoscopic approach was used in the majority of cases (95.8% (23/24)). Most patients had a low anterior resection (95.8% (23/24)). Sixteen patients received a temporary ileostomy (66.7% (16/24)). Three patients suffered perioperative complications (including colonic ischaemia, rectal perforation and arterial bleeding). Five patients (21.7% (5/23)) had an anastomotic leak treated with Ta drainage in two patients. Final pathology revealed negative margins in 95.8% (23/24). TME was considered complete in 87.5% (21/24) overall and in 95% (21/22) when considering only primary cancer cases.
According to our cohort of selected difficult cases, Ta dissection approach helped achieve complete mesorectal excision in complex primary rectal cancer but also allowed for rectal resection in patients with previous rectal surgery. This technique also helped perform a primary anastomosis in these difficult cases.
本研究的目的是回顾我们首批采用经肛门(Ta)入路治疗原发性或复发性直肠癌患者的术后及短期肿瘤学结局。
对2013年至2016年间发生的所有Ta切除术病例进行回顾性病历审查。我们审查了有关病例选择、肿瘤特征、围手术期和术后数据以及最终病理的数据。
共有24名男性接受了原发性(92%(22/24))或复发性直肠癌(8.3%(2/24))手术。4名患者(16.7%(4/24))有既往直肠手术史,2名患者有既往Ta全直肠系膜切除术(TME)史。大多数患者肥胖,58.3%(14/24)的体重指数>30。大多数病例采用腹腔镜入路(95.8%(23/24))。大多数患者进行了低位前切除术(95.8%(23/24))。16名患者接受了临时回肠造口术(66.7%(16/24))。3名患者发生围手术期并发症(包括结肠缺血、直肠穿孔和动脉出血)。5名患者(21.7%(5/23))发生吻合口漏,其中2名患者接受了Ta引流治疗。最终病理显示95.8%(23/24)切缘阴性。总体而言,87.5%(21/24)的TME被认为是完整的,仅考虑原发性癌症病例时,95%(21/22)的TME被认为是完整的。
根据我们选定的疑难病例队列,Ta切除术入路有助于在复杂的原发性直肠癌中实现完整的直肠系膜切除,也允许对有既往直肠手术史的患者进行直肠切除。该技术还有助于在这些疑难病例中进行一期吻合。